Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins

Antiviral Research

Volumn 31, Issue 1-2, 1996, Pages 45-57

  Keulen, Wilco ^a   Boucher, Charles ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Drug resistance; HIV 1; Mutation bias; Reverse transcriptase; Transition transversion

Indexed keywords

1 (1H INDOL 2 YLCARBONYL) 4 [3 (ISOPROPYLAMINO)PYRIDINYL]PIPERAZINE; 3 [(4,7 DICHLORO 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; 6 CHLORO 3,4 DIHYDRO 4 (ISOPROPENYLOXYCARBONYL) 3,3 DIMETHYL 2(1H) QUINOXALINETHIONE; 9 CHLORO 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; ALPHA APA; ATEVIRDINE; DELAVIRDINE; DIDANOSINE; L 697593; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; S 2720; STAVUDINE; TSAO DERIVATIVE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0029885139     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(96)00944-8     Document Type: Article

References (39)

1. Anderson, R.P. and Menninger, J.R. (1986) The accuracy of RNA synthesis. In: T.B.L. Kirkwood, R.F. Rosenberger and D.J. Galas (Eds), Accuracy in Molecular Processes, pp. 159-189. Chapman and Hall, London.
2. Balzarini, J., Karlsson, A., Meichsner, C., Paessens, A., Riess, G., De Clerq, E. and Kleim, J.-P. (1994a) Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxiline S-2720. J. Virol. 68, 7986-7992.
3. Balzarini, J., Karlsson, A., Sardana, V.V., Emini, E.A., Camarasa, M.-J. and de Clerq, E. (1994b) Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K) RT HIV-1 mutants or select for highly resistant (Y181C → C1811) RT HIV-1 mutants. Proc. Natl. Acad. Sci. USA 91, 6599-6603.
4. Bebenek, K. and Kunkel, T.A. (1993) The fidelity of retroviral reverse transcriptases. In: A.M. Skalka and S.P. Goff (Eds), Reverse Transcriptase. Cold Spring Harbor Laboratory, New York.
5. Berkhout, B. and Klaver, B. (1995) Revenants and pseudo-revertants of HIV-1 viruses mutated in the LTR promoter region. J. Gen. Virol. 76, 845-853.
6. Boucher, C.A.B., Cammack, N., Schipper, P., Schuurman, R., Rouse, P., Wainberg, M.A. and Cameron, J.M. (1993) High-level resistance to ( - ) enantiomeric 2′-deoxy-3′-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 37, 2231-2234.
7. Boyer, P.L., Ferris, A.L., Clark, P., Whitmer, J., Frank, P., Tantillo, C., Arnold, E. and Hughes, S.H. (1994) Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J. Mol. Biol. 243, 472-483.
8. Chao, S.-F., Chan, V.L., Juranka, P., Kaplan, A.H., Swanstrom, R. and Hutchison III, C.A. (1995) Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res. 5, 803-810.
9. Chou, P.Y. and Fasman, G.D. (1978) Prediction of secondary structure of proteins from their amino acid sequence. In: A. Meister (Ed), Advances in Enzymology and Related Areas of Molecular Biology, pp. 45-148. John Wiley and Sons, New York.
10. Cinatl Jr., J., Cinatl, J., Rabenau, H., Doerr, H.W. and Weber, B. (1994) Failure of antiviral therapy: role of viral and cellular factors. Intervirolgy 37, 307-314.
11. Coffin, J.M. (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
12. Gao, Q., Gu, Z., Parniak, M.A., Cameron, J., Cammack, N., Boucher, C. and Wainberg, M.A. (1993) The same mutation that encodes low-level human immunodefiency virus type 1 resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine confers high-level resistance to the ( - ) enantiomer of 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37, 1390-1392.
13. Gojobori, T., Li, W.-H. and Graur, D. (1982) Patterns of nucleotide substitution in pseudogenes and functional genes. J. Mol. Evol. 18, 360-369.
14. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
15. Ji, J. and Loeb, L.A. (1994) Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology 199, 323-330.
16. Ji, J., Hoffmann, J.-S. and Loeb, L. (1994) Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis. Nucleic Acids Res. 22, 47-52.
17. Johnson, P.R., Hamm, T.E., Goldstein, S., Kitov, S. and Hirsch, V.M. (1991) The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 185, 217-228.
18. Kellam, P. and Larder, B.A. (1995) Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J. Virol. 69, 669-674.
19. Kellam, P., Boucher, C.A.B. and Larder, B.A. (1992) Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proc. Natl. Acad. Sci. USA 89, 1934-1938.
20. Klaver, B. and Berkhout, B. (1994) Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13, 2650-2659.
21. Kleim, J.-P., Bender, R., Billhardt, U.-M., Meichsner, C., Riess, G., Rosner, M., Winkler, I. and Paessens, A. (1994) Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase. Virology 200, 696-701.
22. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steitz, T.A. (1992) Crystal structure at 3.5A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
23. Lacey, S.F. and Larder, B.A. (1994) Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant for nucleoside analog resistance. J. Virol. 68, 3421-3424.
24. Larder, B.A. (1994) Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. J. Gen. Virol. 75, 951-957.
25. Larder, B.A., Coates, K.E. and Kemp, S.D. (1991) Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J. Virol. 65, 5232-5236.
26. Li, W.-H. and Graur, D. (1991) In: D. Graur (Ed), Fundamentals of Molecular Evolution, pp. 20-41. Sinauer Associates, Inc., Sunderland, MA.
27. Li, W.-H., Wu, C-I. and Luo, C.-C. (1984) Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J. Mol. Evol. 211, 58-71.
28. Mellors, J.W., Im, G.J., Tramontano, E., Winkler, S.R., Medina, D.J., Dutschman, G.E., Bazmi, H.Z., Piras, G., Gonzalez, C.J. and Cheng, Y.C. (1993) A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to ( + )-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5,1-jk]11.4] benzodiazepin-2(1H)-thione(T IBO R82150). Mol. Pharmacol. 43, 11-16.
29. Mellors, J.W., Larder, B.A. and Schinazi, R.F. (1995) Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antiviral News 3, 8-13.
30. Myers, G., Wain-Hobson, S., Henderson, L.E., Korber, B., Jeang, K.-T. and Pavlakis, G.N. (1995) In: G.N. Pavlakis (Ed), Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, NM.
31. Najera, I., Holguin, A., Quinones-Mateu, M.E., Munoz-Fernandez, M.A., Najera, R., Lopez-Galindez, C. and Domingo, E. (1995) Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69, 23-63.
32. Pelletier, E., Saurin, W., Cheynier, R., Letvin, N.L. and Wain-Hobson, S. (1995) The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 208, 644-652.
33. Roberts, J.D., Preston, B.D., Johnston, L.A., Soni, A., Loeb, L.A. and Kunkel, T.A. (1989) Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol. Cell. Biol. 9, 469-476.
34. Schinazi, R.F., Lloyd, R.M., Nguyen, M., Cannon, D.L., McMillan, A., Ilksoy, N., Chu, C.K., Liotta, D.C., Bazmi, H.Z. and Mellors, J.W. (1993) Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37, 875-881.
35. Schinazi, R.F., Lloyd, R.M., Ramanathan, C.S. and Taylor, E.W. (1994) Antiviral drug resistance mutations in human immunodefiency virus type 1 reverse transcriptase occur in specific RNA structural regions. Antimicrob. Agents Chemother. 38, 268-274.
36. Schuurman, R., Nijhuis, M., van Leeuwen, R., Schipper, P., de Jong, D., Collis, P., Danner, S.A., Mulder, J., Loveday, C., Christopherson, C., Kwok, S., Sninsky, J. and Boucher, C.A.B. (1995) Rapid changes in human immunodeficiency virus (HIV-1) RNA load and appearance of drug resistant virus populations in individuals treated with 3TC (lamivudine). J. Infect. Dis. 171, 1411-1419.
37. Shirasaka, T., Kavlick, M.F., Ueno, T., Gao, W.-Y., Kojima, E., Alcaide, M.L., Chokekijchai, S., Roy, B.M., Arnold, E., Yarchoan, R. and Mitsuya, H. (1995) Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92, 2398-2402.
38. Tisdale, M., Kemp, S.D., Parry, N.R. and Larder, B.A. (1993) Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. USA 90, 5653-5656.
39. Wei, X., Ghoosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn. B.H., Saag, M.S. and Shaw, G.M. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.